IN2014DN09774A - - Google Patents

Info

Publication number
IN2014DN09774A
IN2014DN09774A IN9774DEN2014A IN2014DN09774A IN 2014DN09774 A IN2014DN09774 A IN 2014DN09774A IN 9774DEN2014 A IN9774DEN2014 A IN 9774DEN2014A IN 2014DN09774 A IN2014DN09774 A IN 2014DN09774A
Authority
IN
India
Prior art keywords
synthesis
activated
improved
disclosed embodiments
intermediates
Prior art date
Application number
Other languages
English (en)
Inventor
Kelly Kraft
John Freeman
Paul Serwinski
Vinnie Pavia
Otto Phantsiel
Navneet Kaur
Original Assignee
Mannkind Corp
Kelly Kraft
John Freeman
Serwin Ski Paul
Vinnie Pavia
Otto Phantsiel
Navneet Kaur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mannkind Corp, Kelly Kraft, John Freeman, Serwin Ski Paul, Vinnie Pavia, Otto Phantsiel, Navneet Kaur filed Critical Mannkind Corp
Publication of IN2014DN09774A publication Critical patent/IN2014DN09774A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06—Preparation of nitro compounds
    • C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/39—Preparation of carboxylic acid esters by oxidation of groups which are precursors for the acid moiety of the ester

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN9774DEN2014 2012-04-27 2013-03-15 IN2014DN09774A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261639536P 2012-04-27 2012-04-27
PCT/US2013/032162 WO2013162764A1 (en) 2012-04-27 2013-03-15 Methods for the synthesis of ethylfumarates and their use as intermediates

Publications (1)

Publication Number Publication Date
IN2014DN09774A true IN2014DN09774A (zh) 2015-07-31

Family

ID=49477848

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9774DEN2014 IN2014DN09774A (zh) 2012-04-27 2013-03-15

Country Status (16)

Country Link
US (5) US9193691B2 (zh)
EP (1) EP2841422B1 (zh)
JP (1) JP6241682B2 (zh)
KR (1) KR20150023315A (zh)
CN (2) CN104797563B (zh)
AU (2) AU2013252901B2 (zh)
BR (1) BR112014026809A2 (zh)
CA (1) CA2871126C (zh)
HK (1) HK1207382A1 (zh)
IL (1) IL235247A0 (zh)
IN (1) IN2014DN09774A (zh)
MX (1) MX361470B (zh)
RU (1) RU2014143116A (zh)
SG (1) SG11201406970QA (zh)
WO (1) WO2013162764A1 (zh)
ZA (1) ZA201408429B (zh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
ES2300568T3 (es) 2002-03-20 2008-06-16 Mannkind Corporation Aparato de inhalacion.
CA2575692C (en) 2004-08-20 2014-10-14 Mannkind Corporation Catalysis of diketopiperazine synthesis
KR20130066695A (ko) 2004-08-23 2013-06-20 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
CN104324362B (zh) 2005-09-14 2018-04-24 曼金德公司 以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
MX2008010721A (es) 2006-02-22 2008-09-01 Mannkind Corp Un metodo para mejorar las propiedades farmaceuticas de microparticulas que contienen dicetopiperazina y un agente activo.
US8424518B2 (en) 2008-06-13 2013-04-23 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
EP2609954B1 (en) 2008-06-20 2021-12-29 MannKind Corporation An interactive apparatus for real-time profiling of inhalation efforts
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
JP5667095B2 (ja) 2009-03-11 2015-02-12 マンカインド コーポレイション 吸入器の抵抗を測定するための装置、システムおよび方法
KR20180036807A (ko) 2009-06-12 2018-04-09 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
CA2801936C (en) 2010-06-21 2021-06-01 Mannkind Corporation Dry powder drug delivery system and methods
CN103826988B (zh) 2011-04-01 2016-03-09 曼金德公司 用于药物药盒的泡罩包装
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
AU2012328885B2 (en) 2011-10-24 2017-08-31 Mannkind Corporation Methods and compositions for treating pain
CA2871126C (en) * 2012-04-27 2020-07-14 Mannkind Corp. Methods for the synthesis of activated ethylfumarates and their use as intermediates
AU2013289957B2 (en) 2012-07-12 2017-02-23 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
CA2906817C (en) 2013-03-15 2022-01-18 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
MX2016000739A (es) 2013-07-18 2017-04-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3407203A (en) 1965-03-22 1968-10-22 Union Carbide Corp Novel process for the preparation of diketopiperazines
US5352461A (en) * 1992-03-11 1994-10-04 Pharmaceutical Discovery Corporation Self assembling diketopiperazine drug delivery system
DE10019879A1 (de) 2000-04-20 2001-10-25 Degussa Verfahren zur Herstellung von 2,5-Diketopiperazinen, neue 2,5-Diketopiperazine und deren Verwendung
CA2575692C (en) 2004-08-20 2014-10-14 Mannkind Corporation Catalysis of diketopiperazine synthesis
KR20130066695A (ko) 2004-08-23 2013-06-20 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
MX2008010721A (es) * 2006-02-22 2008-09-01 Mannkind Corp Un metodo para mejorar las propiedades farmaceuticas de microparticulas que contienen dicetopiperazina y un agente activo.
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DK2379511T3 (en) * 2008-12-29 2015-01-12 Mannkind Corp Substituted diketopiperazinanaloger for use as pharmaceutical management funds
US8809382B2 (en) * 2009-05-04 2014-08-19 The Royal Institution For The Advancement Of Learning/Mcgill University 5-oxo-ETE receptor antagonist compounds
CN101851213A (zh) 2010-06-21 2010-10-06 于清 3，6-双(4-双反丁烯二酰基氨丁基)-2，5-二酮哌嗪及其盐取代物的合成方法
RU2606624C2 (ru) 2011-02-10 2017-01-10 Маннкайнд, Корп Получение n-защищенного бис-3,6-(4-аминоалкил)-2,5-дикетопиперазина
CA2871126C (en) * 2012-04-27 2020-07-14 Mannkind Corp. Methods for the synthesis of activated ethylfumarates and their use as intermediates

Also Published As

Publication number Publication date
AU2018201397B2 (en) 2019-05-02
EP2841422B1 (en) 2019-08-28
US10858325B2 (en) 2020-12-08
US20230057608A1 (en) 2023-02-23
JP2015519321A (ja) 2015-07-09
US9193691B2 (en) 2015-11-24
IL235247A0 (en) 2014-12-31
MX361470B (es) 2018-12-06
CN104797563A (zh) 2015-07-22
CN104797563B (zh) 2017-12-15
EP2841422A1 (en) 2015-03-04
EP2841422A4 (en) 2016-04-13
ZA201408429B (en) 2021-05-26
US20190010131A1 (en) 2019-01-10
KR20150023315A (ko) 2015-03-05
WO2013162764A1 (en) 2013-10-31
US11479535B2 (en) 2022-10-25
AU2013252901A1 (en) 2014-11-06
CA2871126C (en) 2020-07-14
MX2014013075A (es) 2015-08-14
CN107879938A (zh) 2018-04-06
AU2018201397A1 (en) 2018-03-22
HK1207382A1 (zh) 2016-01-29
RU2014143116A (ru) 2016-06-20
JP6241682B2 (ja) 2017-12-06
BR112014026809A2 (pt) 2017-06-27
US20210114994A1 (en) 2021-04-22
US10071969B2 (en) 2018-09-11
US20130289278A1 (en) 2013-10-31
AU2013252901B2 (en) 2017-11-30
SG11201406970QA (en) 2014-11-27
US20160159753A1 (en) 2016-06-09
CA2871126A1 (en) 2013-10-31

Similar Documents

Publication Publication Date Title
IN2014DN09774A (zh)
MX2011009369A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
PH12014502613A1 (en) Synthesis of heterocyclic compound
WO2012050975A3 (en) Novel circular mammalian rna molecules and uses thereof
MX2013004870A (es) Procedimiento para producir aerogeles o xerogeles.
TNSN08513A1 (en) Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands
PH12014501179B1 (en) New bicyclic dihydroisoquinoline-1-one derivatives
WO2012006440A3 (en) Endothelial cell production by programming
MX2009008284A (es) Compuestos triciclicos y su uso como moduladores de receptor de glucocorticoides.
MA33537B1 (fr) Anticorps anti-cdcp1 humanisés
MX350211B (es) Proceso para la preparacion del etil-ester del acido n- (4-ciclohexil-3-trifluoro-metil-benciloxi) -acetimidico.
MX2011008825A (es) 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
MX2012007341A (es) Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso.
EP2559655A4 (en) METHOD FOR SYNTHESIZING NANOELECTRODE MATERIALS USING ULTRARAPID COMBUSTION PROCESS, AND NANOELECTRODE MATERIALS SYNTHESIZED BY THE METHOD
EA201391618A1 (ru) Комбинация, содержащая умеклидиний и кортикостероид
MX2011008662A (es) 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3.
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
PH12016502534A1 (en) Azaquinazoline carboxamide derivatives
MX354648B (es) Materiales zeoliticos y metodos para su preparacion utilizando compuestos alqueniltrialquilamonio.
MX346507B (es) Proceso para producir 2,3,3,3,-tetrafluoropropeno.
GB201103256D0 (en) Solid support and method of recovering biological material therefrom
EP2418016A4 (en) CATALYST FOR CHLORINE MANUFACTURE AND METHOD FOR CHLORINE PRODUCTION USING THE CATALYST
MX2012006524A (es) Proceso para la sintesis de compuestos intermedios de utilidad para preparar compuestos sustituidos de indazol y azaindol.
EP2613800A4 (en) MATURING THE STOMACH DARM TRAKTS
WO2012053994A3 (en) Ecdysteroid analogues having plant growth promoting activity